Bio-Rad Laboratories, Inc.Class A

BIONYSEUSD
292.65 USD
2.70 (0.93%)🟢LIVE (AS OF 10:11 AM EDT)
🟢Market: OPEN

Bio-Rad Laboratories, Inc.Class A (BIO) is currently trading at $292.65. Our models show a "Buy" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score and a bearish Death Cross on the long-term moving averages. On valuation, BIO trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jun 16, 2026.

Open?$288.78
High?$347.70
Low?$270.77
Prev. Close?$289.95
Volume?28.6K
Avg. Volume?424.0K
VWAP?$289.64
Rel. Volume?0.07x
Bid / Ask
Bid?$288.31 × 40
Ask?$289.97 × 160
Spread?$1.66
Midpoint?$289.14
Valuation & Ratios
Market Cap?7.8B
Shares Out?21.7M
Float?18.1M
Float %?83.4%
P/E Ratio?45.97
P/B Ratio?1.13
EPS?$6.31
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Employees
7.5K
Market Cap
7.7B
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Listed
1980-02-29
Address
1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547
Phone: (510) 724-7000
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Neutral(0/3)
Medium-Term (Wave)? Bullish(+1/3)
Short-Term (Ripple)? Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
79
Momentum?
60
Short Sent.?
61
Piotroski F-Score?3/9Weak
Altman Z-Score?3.27Safe
Confidence?65%Moderate
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?8.32%Elevated
Short Interest?1.5M
Days to Cover?2.6
Free Float18.1M
Avg Daily Volume577.8K
Settlement Date2026-05-29
Financial Health
Current Ratio?3.21Strong
Quick Ratio?2.37Strong
Cash Ratio?0.55Adequate
Debt/Equity?0.18Low
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score
67/100
P/E?
Peers
50
S&P
15
46.0PRICEY
P/B?
Peers
100
S&P
94
1.13CHEAP
P/S?
Peers
91
S&P
51
3.00CHEAP
P/FCF?
Peers
91
S&P
50
21.7FAIR
EV/EBITDA?
Peers
27
S&P
7
36.7HIGH
EV/Sales?
Peers
91
S&P
57
3.26FAIR
Returns & Efficiency
ROE?
Peers
22
S&P
17
2.5%WEAK
ROA?
Peers
10
S&P
17
1.7%WEAK
Cash Flow & Enterprise
FCF?$357.2M
Enterprise Value?$8.5B
Fundamentals ratios updated end of day